CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine

Blood

Volumn 120, Issue 24, 2012, Pages 4829-4839

  Gu, Ying ^a,b,c   Chen, Ting ^a   Meng, Zhipeng ^c   Gan, Yichao ^a   Xu, Xiaohua ^a   Lou, Guiyu ^c   Li, Hongzhi ^c   Gan, Xiaoxian ^d   Zhou, Hong ^a   Tang, Jinfen ^a   Xu, Genbo ^a   Huang, Liansheng ^a   Zhang, Xiaohong ^a   Fang, Yongming ^b   Wang, Kai ^b   Zheng, Shu ^b   Huang, Wendong ^c   Xu, Rongzhen ^a,b  

^a China National Ministry of Education   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BERBAMINE; BETA CATENIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II GAMMA; IMATINIB; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BODY WEIGHT; CANCER STEM CELL; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME INHIBITION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR VOLUME;

EID: 84870737638     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-434894     Document Type: Article

References (47)

1. Hantschel O, Superti-Furga G. Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol. 2004;5(1):33-44. (Pubitemid 38089839)
2. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243(5405):290-293.
3. Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96(10):3343-3356.
4. Stuart SA, Minami Y, Wang JY. The CML stem cell: evolution of the progenitor. Cell Cycle. 2009;8(9):1338-1343.
5. Li S, Li D. Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitors. J Cell Mol Med. 2007;11(6):1251-1262.
6. Konig H, Holtz M, Modi H, et al. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia. 2008;22(4):748-755. (Pubitemid 351552624)
7. Mahon FX, Hayette S, Lagarde V, et al. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Cancer Res. 2008;68(23):9809-9816.
8. Hu Y, Chen Y, Douglas L, Li S. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia. 2009;23(1):109-116.
9. Chen Y, Hu Y, Michaels S, Segal D, Brown D, Li S. Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice. Leukemia. 2009;23(8):1446-1454.
10. Zhang XW, Yan XJ, Zhou ZR, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science. 2010;328(5975):240-243.
11. Titov DV, Gilman B, He QL, et al. XPB, a subunit of TFIIH, is a target of the natural product triptolide. Nat Chem Biol. 2011;7(3):182-188.
12. Kupeli E, Kosar M, Yesilada E, Husnu K, Baser C. A comparative study on the anti-inflammatory, anti-nociceptive and anti-pyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci. 2002;72(6):645-657. (Pubitemid 35441232)
13. Tsai TH. Analytical approaches for traditional chinese medicines exhibiting anti-neoplastic activity. J Chromatogr B Biomed Sci Appl. 2001;764(1-2):27-48.
14. Ren Y, Lu L, Guo TB, et al. Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis. J Immunol. 2008;181(2):1491-1498.
15. Seow WK, Ferrante A, Summors A, Thong YH. Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor. Life Sci. 1992;50(8):PL53-PL58.
16. Liu J, Qi S, Zhu H, Zhang J, Li Z, Wang T. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo. Chin Med J (Engl). 2002;115(5):759-762. (Pubitemid 34594297)
17. Xu R, Dong Q, Yu Y, et al. Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leuk Res. 2006;30(1):17-23. (Pubitemid 41654699)
18. Xie J, Ma T, Gu Y, et al. Berbamine derivatives: a novel class of compounds for anti-leukemia activity. Eur J Med Chem. 2009;44(8):3293-3298.
19. Liang Y, Qiu X, Xu RZ, Zhao XY. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity. J Zhejiang Univ Sci B. 2011;12(7):568-574.
20. Wei YL, Liang Y, Xu L, Zhao XY. The anti-proliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. Anat Rec (Hoboken). 2009;292(7):945-950.
21. Zhao XY, He ZW, Wu D, Xu RZ. Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway. Chin Med J (Engl). 2007;120(9):802-806. (Pubitemid 46767828)
22. Du HP, Shen JK, Yang M, et al. 4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells. Oncol Rep. 2010;23(3):709-716.
23. Liang Y, Xu RZ, Zhang L, Zhao XY. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells. Acta Pharmacol Sin. 2009;30(12):1659-1665.
24. Liu R, Zhang Y, Chen Y, et al. A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells. J Pharm Sci. 2010;99(7):3266-3275.
25. Duan H, Luan J, Liu Q, Yagasaki K, Zhang G. Suppression of human lung cancer cell growth and migration by berbamine. Cytotechnology. 2010;62(4):341-348.
26. Wang GY, Lv QH, Dong Q, Xu RZ, Dong QH. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J Asian Nat Prod Res. 2009;11(3):219-228.
27. Wang S, Liu Q, Zhang Y, et al. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer. 2009;8:81.
28. Xu YH, Zhang SP. A derivative of bisbenzylisoquinoline alkaloid is a new and potential calmodulin antagonist. Biochem Biophys Res Commun. 1986;140(1):461-467.
29. Zhu HJ, Liu GQ. Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells. Acta Pharmacol Sin. 2003;24(11):1143-1149.
30. Akiba S, Nagatomo R, Ishimoto T, Sato T. Effect of berbamine on cytosolic phospholipase A2 activation in rabbit platelets. Eur J Pharmacol. 1995;291(3):343-350.
31. Hu ZY, Chen SL, Hao ZG, Huang WL, Peng SX. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase. Cell Signal. 1989;1(2):181-185.
32. Ji ZN, Ye WC, Liu GQ, Huang Y. Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells. Planta Med. 2002;68(7):596-600. (Pubitemid 34827923)
33. Hu ZY, Gong YS, Huang WL. Interaction of berbamine compound E6 and calmodulin-dependent myosin light chain kinase. Biochem Pharmacol. 1992;44(8):1543-1547.
34. Yanagihara N, Tachikawa E, Izumi F, Yasugawa S, Yamamoto H, Miyamoto E. Staurosporine: an effective inhibitor for Ca2+/calmodulin-dependent protein kinase II. J Neurochem. 1991;56(1):294-298. (Pubitemid 21901963)
35. Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest. 2011;121(1):396-409.
36. Hamilton A, Helgason GV, Schemionek M, et al. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood. 2012;119(6):1501-1510.
37. Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 2001;98(8):2301-2307.
38. Hughes K, Edin S, Antonsson A, Grundstrom T. Calmodulin-dependent kinase II mediates T cell receptor/CD3- and phorbol ester-induced activation of IkappaB kinase. J Biol Chem. 2001;276(38):36008-36013.
39. Si J, Collins SJ. Activated Ca2+/calmodulindependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation. Cancer Res. 2008;68(10):3733-3742.
40. Kim DJ, Kataoka K, Rao D, Kiguchi K, Cotsarelis G, Digiovanni J. Targeted disruption of stat3 reveals a major role for follicular stem cells in skin tumor initiation. Cancer Res. 2009;69(19):7587-7594.
41. Sherry MM, Reeves A, Wu JK, Cochran BH. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells. 2009;27(10):2383-2392.
42. Greathouse GA, Rigler NE. Isolation of the Alkaloids, Berberine and Berbamine, from Mahonia Swaseyi. Plant Physiol. 1940;15(3):563-564.
43. Si J, Mueller L, Collins SJ. CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells. J Clin Invest. 2007;117(5):1412-1421. (Pubitemid 46718429)
44. Ang ES, Zhang P, Steer JH, et al. Calcium/calmodulindependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL). J Cell Physiol. 2007;212(3):787-795. (Pubitemid 47267548)
45. Marganski WA, Gangopadhyay SS, Je HD, Gallant C, Morgan KG. Targeting of a novel Ca+2/calmodulin-dependent protein kinase II is essential for extracellular signal-regulated kinase-mediated signaling in differentiated smooth muscle cells. Circ Res. 2005;97(6):541-549. (Pubitemid 41361744)
46. Bouallegue A, Pandey NR, Srivastava AK. CaMKII knockdown attenuates H2O2-induced phosphorylation of ERK1/2, PKB/Akt, and IGF-1R in vascular smooth muscle cells. Free Radic Biol Med. 2009;47(6):858-866.
47. Li BX, Gao YD, Li WH. Determination of berbamine in rat plasma by reversed phase high performance liquid chromatography. J Harbin Med Univ. 1995;29(3):201-203.